VivoSeq
Other

Ropivacaine

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Ropivacaine is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

23

clinical trials

Completed15 · 65%
Unknown status5 · 22%
Terminated2 · 9%
Recruiting1 · 4%

Trial Activity

23 trials

Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic Block
Completed··Phase 4·NCT00567450·30 enrolled
Ropivacaine After Sternotomy
Completed·KKuopio University Hospital·Phase 4·NCT02449486·90 enrolled
Pharmacokinetic of Thoracic Paravertebral Ropivacaine
Completed··N/A·NCT03721406·20 enrolled
Effect of Sufentanil and Ropivacaine
Completed·FFudan University·N/A·NCT02488291·120 enrolled
Clonidine - Ropivacaine in Peribulbar Anesthesia
Completed··Phase 2·NCT01963299·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)